Cheat sheet

NAPLEX Cheat Sheet

Practice this exam

Foundational Knowledge

  • 25% of exam
  • PK Core Calculations Biostatistics Compounding Evidence

Medication Use Process

  • 25% of exam
  • Orders Substitution Immunizations Handling Medication Use Picker

Assessment and Treatment

  • 40% of exam
  • History Therapy Fit Monitoring Counseling Therapy Picker

Professional Practice

  • 5% of exam
  • Reporting Public Health Ethics Social Drivers

Management and Leadership

  • 5% of exam
  • Operations Inventory Quality Leadership

Quick Facts

  • Exam NAPLEX
  • Owner NABP
  • Delivery Pearson VUE
  • Time 6 hours
  • Questions 225 total
  • Scored 200 scored
  • Pass 75 scaled
  • Result Pass/fail
  • Attempts 5 total
  • Blueprint May 1 2025

PK Triad FO

  • Vd, clearance, half-life travel together.
  • Vd Cl t1/2 ke

Scored vs Pretest FO

Scored

  • 200 items
  • Counts toward pass

Pretest

  • 25 items
  • Not identified
  • Treat every item as scored

Calculation Picker FO

  • Renal dosing → Cockcroft-Gault ( Use CrCl )
  • Weight dose → mg/kg ( Convert kg )
  • Manual drip → gtt/min ( Drop factor )
  • Infusion pump → mL/hr ( Concentration first )
  • Electrolyte amount → mEq ( Valence matters )
  • Nutrition calories → TPN math ( Macros separate )
  • Chemo dosing → BSA ( Verify caps )
  • Mix strengths → Alligation ( Percent check )

PK Core FO

  • ADME Drug movement
  • Vd Amount over concentration
  • Cl Removal efficiency
  • t1/2 Concentration halves
  • ke Elimination constant
  • AUC Total exposure
  • Css Steady state
  • F Bioavailability fraction

First vs Zero Order FO

First-order

  • Constant fraction
  • Stable half-life

Zero-order

  • Constant amount
  • Capacity saturated
  • Phenytoin can saturate

Calculations FO

  • lb to kg Divide by 2.2
  • mg/kg Dose times weight
  • mL/hr Volume over hours
  • gtt/min mL/hr times factor
  • mEq mg times valence/MW
  • mOsm Particles per liter
  • CrCl Cockcroft-Gault dosing
  • BSA Mosteller formula

ARR vs RRR FO

ARR

  • Absolute difference
  • Needed for NNT

RRR

  • Relative reduction
  • Can look larger
  • NNT uses ARR

Evidence FO

  • P value Chance under null
  • CI Estimate precision
  • ARR Absolute risk difference
  • RRR Relative risk drop
  • NNT One benefit count
  • NNH One harm count
  • Bias Systematic error
  • Power Detects true effect

Compounding FO

  • USP 795 Nonsterile compounding
  • USP 797 Sterile compounding
  • USP 800 Hazardous drugs
  • BUD Beyond-use date
  • Aseptic Prevents contamination
  • CSP Sterile preparation
  • Incompatibility Physical or chemical
  • Stability Potency maintained

Five Rights ME

  • Patient, drug, dose, route, time.
  • Patient Drug Dose Route Time

Contraindication vs Precaution ME

Contraindication

  • Do not give
  • Risk unacceptable

Precaution

  • Assess first
  • May delay
  • Contraindication blocks therapy

Medication Use Picker ME

  • Unclear order → Clarify ( Before dispense )
  • Contraindicated drug → Hold ( Contact prescriber )
  • Formulary issue → Therapeutic alternative
  • Shortage exists → Reserve supply ( Clinical priority )
  • Vaccine adverse event → VAERS
  • Temperature breach → Quarantine ( Check stability )

Orders ME

  • Indication Why drug needed
  • Dose Amount per administration
  • Route How administered
  • Frequency How often
  • Duration Treatment length
  • Allergy Avoid trigger
  • Contraindication Do not use
  • Boxed warning Serious risk

Medication Use ME

  • Prescribing Therapy ordered
  • Transcribing Order documented
  • Dispensing Product supplied
  • Administering Dose given
  • Monitoring Response checked
  • Substitution Alternative selected
  • Shortage Supply limited
  • REMS Risk program

Immunizations ME

  • Indication Vaccine recommended
  • Contraindication Vaccine avoided
  • Precaution Assess risk
  • Live vaccine Avoid immunocompromise
  • Cold chain Temperature control
  • VIS Patient handout
  • VAERS Vaccine event report
  • ACIP Schedule guidance

Handling ME

  • Storage Required conditions
  • Excursion Temperature breach
  • Quarantine Hold product
  • Hazardous Special controls
  • Sharps Puncture container
  • Disposal Safe removal
  • Recall Product removed
  • Chain Custody trace

Therapy Problems PA

  • Need, fit, dose, safety, adherence.
  • Indication Effectiveness Safety Adherence

Interaction vs Duplication PA

Interaction

  • Exposure changes
  • Toxicity or failure

Duplication

  • Same purpose
  • Unneeded overlap
  • Check both every profile

Therapy Picker PA

  • No indication → Stop therapy ( Avoid harm )
  • Untreated condition → Add therapy
  • Goal unmet → Intensify ( If adherent )
  • ADR likely → Switch therapy
  • Renal decline → Adjust dose
  • Poor adherence → Simplify regimen

History PA

  • PMH Disease history
  • Med list All therapies
  • Allergies Reaction details
  • Adherence Actual use
  • Pregnancy Fetal risk
  • Renal Dose adjustment
  • Hepatic Metabolism risk
  • Social Care barriers

Efficacy vs Safety PA

Efficacy

  • Goal achieved
  • Disease controlled

Safety

  • Harms acceptable
  • Labs stable
  • Passing answers balance both

Therapy Fit PA

  • Indication Needs therapy
  • Efficacy Meets goal
  • Safety Harms acceptable
  • Duplication Same purpose
  • Omission Missing therapy
  • Interaction Exposure altered
  • ADR Drug harm
  • Toxicity Excess exposure

Monitoring PA

  • Goal Target outcome
  • Endpoint Measured result
  • Baseline Starting value
  • Follow-up Recheck timing
  • Lab Objective measure
  • Vitals Clinical signs
  • TDM Drug concentration
  • Deprescribe Stop safely

High-Yield Therapy PA

  • HTN BP goal therapy
  • Diabetes A1c plus comorbidities
  • HFrEF Four pillars
  • AFib Stroke prevention
  • ID Site and organism
  • Asthma Controller plus reliever
  • Psych Efficacy plus safety
  • Pain Function and risk

Reporting Split PR

  • Vaccines to VAERS; drugs to MedWatch.
  • VAERS MedWatch Safety Signal

MedWatch vs VAERS PR

MedWatch

  • Drugs/devices
  • FDA safety

VAERS

  • Vaccines
  • Adverse events
  • Vaccine event goes VAERS

Practice Safety PR

  • MedWatch Drug event report
  • VAERS Vaccine event report
  • Stewardship Optimize antimicrobials
  • Naloxone Opioid reversal
  • Cessation Tobacco treatment
  • SDOH Access barriers
  • Autonomy Patient choice
  • Confidentiality Protect privacy

Quality Cycle MA

  • Plan, do, study, act.
  • Plan Do Study Act

RCA vs PDSA MA

RCA

  • Find system causes
  • After event

PDSA

  • Test improvements
  • Iterative cycle
  • Analyze then improve

Safety Picker MA

  • High-alert drug → Double-check
  • Name confusion → Tall man
  • System error → RCA
  • Process trend → CQI ( PDSA cycle )
  • Serious recall → Class I ( Act immediately )
  • Inventory mismatch → Cycle count

Operations MA

  • ADC Automated dispensing
  • BCMA Barcode administration
  • CPOE Electronic ordering
  • LASA Name confusion
  • Tall man Name differentiation
  • Double-check Independent verification
  • Just culture Systems focus
  • High-alert Severe harm risk

Inventory + Quality MA

  • Cycle count Rotating inventory count
  • Perpetual Real-time inventory
  • Class I Serious recall
  • Class II Reversible risk
  • Class III Unlikely harm
  • MUE Medication use review
  • RCA System cause analysis
  • PDSA Improvement cycle

Common Traps

75 Scaled

  • Not 75 percent ≠ Competency threshold

Pass Result

  • Numeric score hidden ≠ Fail report detailed

No Backtracking

  • No skipped items ≠ No later review

CrCl Dosing

  • Cockcroft-Gault ≠ Not eGFR default

Pretest Items

  • Mixed into exam ≠ Not marked

Live Vaccines

  • Avoid immunocompromise ≠ Inactivated usually safer

High-Alert Drugs

  • Not common drugs ≠ Severe harm drugs

Recall Classes

  • Class I serious ≠ Class III least harmful

Last Minute

  • 1. Domain 3 is 40%
  • 2. Use 200 scored weights
  • 3. 225 questions, 6 hours
  • 4. Each answer locks
  • 5. Treat all items scored
  • 6. CrCl for renal dosing
  • 7. NNT equals one over ARR
  • 8. Five rights before administer
  • 9. Quarantine temperature excursions
  • 10. VAERS for vaccine events
  • 11. MedWatch for drug events
  • 12. RCA finds system causes

NABP NAPLEX North American Pharmacist Licensure Examination

  • Practice Questions 200 questions Study Guide 20 topics Cheat Sheet 120 facts Flashcards 50 cards Videos 3 videos Blogs 3 blogs Free CE Podcast